Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Xcessbio SCR7 10MM DMSO (0.598ML)

Supplier:  Xcessbio M600822S

Encompass_Preferred

Product Information Molecular Weight: 334.39 Formula: C18H14N4OS Purity: >= 98%. Solubility: DMSO up to 50 mM Chemical Name: 5,6-bis((E)-benzylideneamino)-2-mercaptopyrimidin-4-ol Storage: Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year. Biological activity: SCR7 is a potent and selective inhibitor of non-homologous end joining (NHEJ). It inhibits joining of DSBs in cell-free DNa repair system, blocks Ligase IV-mediated joining by interfering with its DNa binding but not that of T4 DNa Ligase or Ligase I, thereby leading to accumulation of DSBs within the cells, culminating into cytotoxicity. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models, and when co-administered with DSB-inducing therapeutic modalities it enhances their sensitivity significantly. In addition, SCR7 can promote the efficiency of HDR 4-5-fold for CRISPR editing in both h 1533426-72-0

Catalog No. NC0769142


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.